Pleural thickness after neoadjuvant chemotherapy is a prognostic factor in malignant pleural mesothelioma
- 31 December 2018
- journal article
- conference paper
- Published by Elsevier BV in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 157 (1), 404-413
- https://doi.org/10.1016/j.jtcvs.2018.09.106
Abstract
No abstract availableKeywords
Funding Information
- Elli Lilly Company
- Taiho Pharmaceuticals
- Ono Pharmaceuticals
This publication has 26 references indexed in Scilit:
- Initial Analysis of the International Association For the Study of Lung Cancer Mesothelioma DatabaseJournal of Thoracic Oncology, 2012
- Summary of Prognostic Factors and Patient Selection for Extrapleural Pneumonectomy in the Treatment of Malignant Pleural MesotheliomaAnnals of Surgical Oncology, 2011
- Volumetry: an alternative to assess therapy response for malignant pleural mesothelioma?European Respiratory Journal, 2011
- Imaging in pleural mesothelioma: A review of Imaging Research Presented at the 9th International Meeting of the International Mesothelioma Interest GroupLung Cancer, 2010
- Surgical assessment of malignant pleural mesothelioma: have we reached a critical stage?European Journal of Cardio-Thoracic Surgery, 2010
- Three-dimensional evaluation of chemotherapy response in malignant pleural mesotheliomaEuropean Journal of Radiology, 2010
- Current Trends in Radiologic Management of Malignant Pleural MesotheliomaSeminars in Thoracic and Cardiovascular Surgery, 2009
- Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: Results in 663 patientsThe Journal of Thoracic and Cardiovascular Surgery, 2008
- Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomiesThe Journal of Thoracic and Cardiovascular Surgery, 2004
- Preoperative Tumor Volume Is Associated With Outcome In Malignant Pleural MesotheliomaThe Journal of Thoracic and Cardiovascular Surgery, 1998